Future research directions in asthma: An NHLBI Working Group Report

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 6, 2004, Pages 683-690

  Busse, William ^b   Banks Schlegel, Susan ^a   Noel, Patricia ^b   Ortega, Hector ^b   Taggart, Virginia ^b   Elias, Jack ^b  

^a DLD/NHLBI   (United States)

^b NONE

Author keywords

Airway lung disease; Asthma; Asthma exacerbations; Asthma genetics; Innate immunity

Indexed keywords

ANGIOPOIETIN; CORTICOSTEROID; GLUCOCORTICOID; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ASTHMA; CHRONICITY; CONFERENCE PAPER; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FUTUROLOGY; GENE INTERACTION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MEDICAL RESEARCH; MORBIDITY; PHARMACOGENETICS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VASCULARIZATION;

ASTHMA; FORECASTING; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH; UNITED STATES;

EID: 4444341708     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200311-1539WS     Document Type: Conference Paper

References (53)

1. Busse W, Elias J, Sheppard D, Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999;160:1035-1042.
2. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodeling in asthma. Chest 2003;123:417S-422S.
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
4. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3:715-720.
5. Braun-Fahrlander C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003;3:325-329.
6. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001;106:259-262.
7. Kumar SD, Emery MJ, Atkins ND, Danta I, Wanner A. Airway mucosal blood flow in bronchial asthma. Am J Respir Crit Care Med 1998;158:153-156.
8. Guilbert T, Krawiec M. Natural history of asthma. Pediatr Clin North Am 2003;50:523-538.
9. Szefler SJ. Identifying the child in need of asthma therapy. Pediatr Clin North Am 2003;50:577-591.
10. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-179.
11. Kelly WJ, Hudson I, Raven J, Phelan PD, Pain MC, Olinsky A. Childhood asthma and adult lung function. Am Rev Respir Dis 1988;138:26-30.
12. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-136.
13. Castro M, Bloch S, Jenkerson M, DeMartino S, Hamilos R, Cochran R, Zhang XE, Wang H, Bradley JP, Schechtman KB. Asthma exacerbations after glucocorticoid withdrawal reflect T cell but not eosinophil recruitment to the airway. Am J Respir Crit Care Med 2004;169:842-849.
14. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:1001-1008.
15. Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR. NHLBI Workshop summary. Stress and asthma. Am J Respir Crit Care Med 1995;151:249-252.
16. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997;156:787-793.
17. Castro M, Schechtman KB, Halstead J, Bloomberg G. Risk factors for asthma morbidity and mortality in a large metropolitan city. J Asthma 2001;38:625-635.
18. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. 1997. National Institutes of Health; National Heart, Lung, and Blood Institute.
19. Panettieri RA Jr. Airway smooth muscle: an immunomodulatory cell. J Allergy Clin Immunol 2002;110:S269-S274.
20. Panettieri RA Jr. Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 2003;137:277-293.
21. Panettieri RA Jr. Airway smooth muscle: an immunomodulatory cell. J Allergy Clin Immunol 2002;110:S269-S274.
22. Panettieri RA Jr. Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 2003;137:277-293.
23. Hoffjan S, Ober C. Present status on the genetic studies of asthma. Curr Opin Immunol 2002;14:709-717.
24. Colilla S, Nicolae D, Pluzhnikov A, Blumenthal MN, Beaty TH, Bleecker ER, Lange EM, Rich SS, Meyers DA, Ober C. Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure. J Allergy Clin Immunol 2003;111:840-846.
25. Vercelli D, Baldini M, Stern D, Lohman IC, Halonen M, Martinez F. CD14: a bridge between innate immunity and adaptive IgE responses. J Endotoxin Res 2001;7:45-48.
26. Werner M, Topp R, Wimmer K, Richter K, Bischof W, Wjst M, Heinrich J. TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003;112:323-330.
27. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 1997;350:995-999.
28. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-3188.
29. Kotani Y, Nishimura Y, Maeda H, Yokoyama M. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J Asthma 1999;36:583-590.
30. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma. Int Arch Allergy Immunol 2001;124:183-186.
31. Drazen JM, Yandava CN, Dube L, Szczerback N, Hippensteel R, Pillari A, Israel E, Schork N, Silverman ES, Katz DA. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999;22:168-170.
32. Liu AH. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 2002;109:379-392.
33. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869-877.
34. Gern JE, Lemanske RF Jr, Busse WW. Early life origins of asthma. J Clin Invest 1999;104:837-843.
35. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol 2003;111:661-675.
36. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414-1422.
37. Stein RT, Holberg CJ, Sherrill D, Wright AL, Morgan WJ, Taussig L, Martinez FD. Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study. Am J Epidemiol 1999;149:1030-1037.
38. Braun-Fahrlander C. Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 2003;3:325-329.
39. Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 2002;288:963-972.
40. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001;357:752-756.
41. McIntire JJ, Umetsu SE, Macaubas C, Hoyte EG, Cinnioglu C, CavalliSforza LL, Barsh GS, Hallmayer JF, Underhill PA, Risch NJ. Immunology: hepatitis A virus link to atopic disease. Nature 2003;425:576.
42. Umetsu DT, Akbari O, DeKruyff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 2003;112:480-487.
43. Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-256.
44. Broide D, Raz E. DNA-Based immunization for asthma. Int Arch Allergy Immunol 1999;118:453-456.
45. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3:253-257.
46. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3:253-257.
47. Wilson JW, Kotsimbos T. Airway vascular remodeling in asthma. Curr Allergy Asthma Rep 2003;3:153-158.
48. Boulay ME, Boulet LP. Airway response to low-dose allergen exposure in allergic nonasthmatic and asthmatic subjects: eosinophils, fibronectin, and vascular endothelial growth factor. Chest 2003;123:430S.
49. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001;107:1034-1038.
50. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-463.
51. Brieva J, Wanner A. Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. J Appl Physiol 2001;90:665-669.
52. Toppila S, Paavonen T, Laitinen A, Laitinen LA, Renkonen R. Endothelial sulfated sialyl Lewis x glycans, putative L-selectin ligands, are preferentially expressed in bronchial asthma but not in other chronic inflammatory lung diseases. Am J Respir Cell Mol Biol 2000;23:492-498.
53. Lazaar AL, Panettieri R. Am J Med 2003;115:652-659.